Showing 2341-2350 of 5064 results for "".
Psoriasis Update 2025: Dr. Gelfand
https://practicaldermatology.com/programs/practical-dermatology/psoriasis-update-2025-dr-gelfand/32672/Joel Gelfand, MD, MSCE, discusses highlights from the "Psoriasis Update 2025" panel at Maui Derm 2025, including the potential for combining TNF inhibitors with IL-23 inhibitors; home phototherapy; and the possibility of GLP-1 agonists lowering the severity of psoriatic disease.Do Not Be Afraid of an ICD-10 Armageddon
https://practicaldermatology.com/topics/practice-management/do-not-be-afraid-of-an-icd-10-armageddon/21406/Practices that prepare will weather ICD-10 and other requirements.2015 Fourth Quarter Tax Saving Tips
https://practicaldermatology.com/topics/practice-management/2015-fourth-quarter-tax-saving-tips/21088/What to do now to save $10,000-$25,000 or more on your 2015 taxes.What’s New in Nonmelanoma Skin Cancer Treatment?
https://practicaldermatology.com/topics/skin-cancer-photoprotection/whats-new-in-nonmelanoma-skin-cancer-treatment/23895/Recent research explores a growing range of nonsurgical options.Hitting the Target in Atopic Dermatitis: Interdisciplinary Team Training for Leveraging IL-13 Inhibitors to Address the Burden of Disease
https://practicaldermatology.com/programs/cme/hitting-the-target-in-atopic-dermatitis-interdisciplinary-team-training-for-leveraging-il-13-inhibitors-to-address-the-burden-of-disease/54437/On-demand webcast on the role of interleukin (IL)-13 in atopic dermatitis pathophysiology and strategies for leveraging IL-13 inhibitors to address disease burden and improve patient outcomes.Spotlight on COVID-19 Related Hair Loss
https://practicaldermatology.com/topics/hair-nails/spotlight-on-covid-19-related-hair-loss/23667/CSF faculty members discuss COVID-19 related hair loss, its treatments, and its implicationsTest Your Skills and Learn From Experts on IL-13 Inhibitors in Moderate to Severe Atopic Dermatitis
https://practicaldermatology.com/programs/cme/test-your-skills-and-learn-from-experts-on-il-13-inhibitors-in-moderate-to-severe-atopic-dermatitis/37624/Watch an expert-led case discussion on the role of IL-13 in moderate to severe atopic dermatitis and the efficacy on its inhibition through biologic therapies to achieve control.Update on COVID-19 Vaccines and Dermal Fillers
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/update-on-covid-19-vaccines-and-dermal-fillers/23451/CSF faculty discuss risks of delayed facial swelling in filler patients following COVID-19 vaccination.DermWireTV: Vtama Approved; Monkey Pox; AbbVie Scholarship; LRP Pride in Dermatology
https://practicaldermatology.com/topics/psoriasis/dermwiretv-vtama-approved-monkey-pox-abbvie-scholarship-lrp-pride-in-dermatology/20097/Vtama (tapinarof) cream 1% from Dermavant is approved for the treatment of psoriasis in adults. Tapinarof is an aryl hydrocarbon receptor agonist. As a public health service, VisualDx is offering pictures of monkey pox and disease information to support clinical decision-making. Forty-five scholarshPractical Dermatology Roundtable: The Role of Adjuvant Skin Cleansing and Moisturizing in Treating Psoriasis and Other Inflammatory Diseases, Ch. 7
https://practicaldermatology.com/programs/the-practical-dermatology-roundtable/practical-dermatology-roundtable-the-role-of-adjuvant-skin-cleansing-and-moisturizing-in-treating-psoriasis-and-other-inflammatory-diseases-ch-7/56875/In the seventh installment of this eight-part series, host Ted Lain, MD, MBA, FAAD, and guests Zoe Diana Draelos, MD, and Firas George Hougeir, MD, FAAD, shift to clinical applications, including maintenance therapy, steroid-sparing strategies, and opportunities for future research.1 Draelos Z, Hou